Allogene Therapeutics, Inc. (ALLO) Presents at Citi's SMID Call Series 2025 Transcript

Allogene Therapeutics, Inc. ( NASDAQ: ALLO) Citi's SMID Call Series 2025 October 2, 2025 1:00 PM EDT ...
Hosted on MSN

Sheffield leads UK trial into stem cell treatment for severe scleroderma

Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and ...
FierceBiotech

AnaptysBio plans to split biotech and Jemperli royalties into separate businesses

AnaptysBio plans to split into two publicly traded companies, with one entity taking forward the biopharma’s clinical-stage pipeline and the other overseeing its royalty-based agreements. The crown ...
Human Rights Watch

UN Official Addresses Need for Colonial, Enslavement Era Reparations

Volker Türk, the United Nations High Commissioner for Human Rights, stressed the need and urgency for comprehensive reparatory justice for historical and ongoing harm linked to colonialism and ...